GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,529,739 | -33.3% | 2,514,443 | -3.2% | 0.45% | -19.1% |
| Q2 2023 | $14,285,898 | +25.5% | 2,597,436 | -1.9% | 0.56% | +10.3% |
| Q1 2023 | $11,387,677 | -0.2% | 2,648,297 | -8.8% | 0.50% | +23.0% |
| Q4 2022 | $11,409,545 | -28.7% | 2,903,192 | -3.7% | 0.41% | -29.4% |
| Q3 2022 | $16,003,000 | -12.0% | 3,013,712 | +8.7% | 0.58% | -16.6% |
| Q2 2022 | $18,193,000 | +331.6% | 2,773,313 | +382.9% | 0.69% | +339.2% |
| Q1 2022 | $4,215,000 | – | 574,278 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |